Syneos Health’s Value and Access team recently discussed with MM&M a range of issues impacting the pharmaceutical industry’s approach to product pricing and commercialization.
Pat Leary, executive vice president of clinical field teams and market access and deployment solutions, tells MM&M the discussion had shifted.
“In the past, (the approach) would be all about, ‘How are you going to commercialize the product? How big should your sales force be? Where should it be deployed?'” Leary said. “Now it starts with, ‘What’s your pricing strategy? What’s your trade distribution strategy? What’s your product’s value? And how are you going to craft that story to be able to get access?”
To read the full discussion, click here.